Non-small cell lung cancer
RecruitingA study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer
A study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer
- Disease:Non-small cell lung cancer
- Substances:DocetaxelDatopotamab Deruxtecan
Hungary- Participants:18–64 years · 65+ years
- Substances:Docetaxel
